Clinical Trial

Long-term Safety of Danicopan: IPIG Registry-based Cohort Study

Name: Long-term Safety of Danicopan: IPIG Registry-based Cohort Study — clinical trial record (NCT07413679)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This is a noninterventional cohort study using primary and secondary data from the International PNH Interest Group (IPIG) PNH registry. It is designed to characterize the long-term safety and tolerability of danicopan as add-on therapy to eculizumab or ravulizumab in adult participants with PNH.

Trial Details

NCT Number	NCT07413679
Lead Sponsor	Alexion Pharmaceuticals, Inc.
Conditions	Paroxysmal Nocturnal Hemoglobinuria, PNH
Enrollment	50 participants
Start Date	2025-08-18
Primary Completion	2029-07-01 (estimated)
Study Completion	2029-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-17